GO:0004675 transmembrane receptor protein serine/threonine kinase activity

Transmembrane receptor protein serine/threonine kinase activity (GO:0004675) is a molecular function that combines signal binding with catalytic transfer of phosphate from ATP to serine or threonine residues on protein substrates, thereby transmitting information from one side of a membrane to the other. This activity is central to how cells sense and respond to extracellular cues such as growth factors, cytokines and morphogens, and it is best exemplified by the TGF-beta superfamily receptors, which include TGFBR1, TGFBR2, ACVR1, BMPR1A and BMPR2. Because these receptors directly couple ligand binding to intracellular phosphorylation, they serve as entry points for a wide range of signaling outputs, including SMAD-dependent and non-Smad pathways. Researchers study GO:0004675 to understand how cells convert extracellular signals into changes in gene expression, cytoskeletal organization and metabolism. The activity is not limited to canonical SMAD signaling; it also engages MAPK, PI3K-AKT, Rho-like GTPase and other cascades, which broadens its impact on proliferation, differentiation, migration and survival. In human disease, altered transmembrane receptor serine/threonine kinase activity has been linked to cancer, fibrosis and vascular remodeling, and the receptors are actively pursued as therapeutic targets. This article provides a research-grade overview of GO:0004675, covering its definition, biological process, cellular components, molecular mechanism, key genes, disease relevance, and the CRISPR-based models and methods used to study it.

GO:0004675, transmembrane receptor protein serine/threonine kinase activity, is defined as combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. In other words, it is a receptor-linked enzymatic activity that spans a membrane, binds an extracellular or membrane-associated signal, and phosphorylates serine or threonine residues on protein targets to propagate the signal inside the cell.

GO:0004675 is important because it defines the first catalytic step by which many transmembrane receptors convert extracellular signals into intracellular phosphorylation events. This activity controls fundamental processes such as cell proliferation, differentiation, migration and survival, and its dysregulation is implicated in cancer, fibrosis and vascular remodeling. Understanding the precise kinetics, substrate specificity and regulation of these receptor kinases is therefore essential for both basic biology and therapeutic development.

The following genes encode receptors or core pathway components that carry out or directly support transmembrane receptor protein serine/threonine kinase activity (GO:0004675).

Transmembrane receptor protein serine/threonine kinase activity is tightly regulated at multiple levels. Ligand availability and receptor complex assembly control the initial activation step, while inhibitory SMADs such as SMAD6 and SMAD7 provide negative feedback on SMAD-dependent signaling. Non-Smad branches, including MAPK and PI3K-AKT, are also subject to crosstalk and feedback regulation that shapes the overall response. In addition, receptor trafficking, ubiquitination and degradation determine the duration of active signaling, and phosphatases reverse the phosphorylation events catalyzed by the receptor kinase.

Altered transmembrane receptor serine/threonine kinase activity is frequently observed in cancer, where it can promote proliferation, epithelial-to-mesenchymal transition and metastasis through SMAD-dependent and non-Smad pathways. Mutations or expression changes in receptors such as TGFBR2 and downstream SMADs can rewire signaling to favor tumor progression.

Receptor serine/threonine kinase signaling contributes to vascular remodeling and fibrosis, and DDR1, a related receptor, has been shown to counteract the Hippo pathway to orchestrate arterial stiffening. This highlights how receptor-linked phosphorylation events can influence extracellular matrix and vascular mechanics.

Because these receptors control differentiation and morphogenesis, disruptions in their kinase activity can lead to developmental abnormalities affecting bone, muscle and other tissues. BMP and activin receptor signaling are particularly important in skeletal and stem cell biology.

Phosphoproteomics can identify serine and threonine phosphorylation events directly catalyzed by transmembrane receptor kinases, providing a global view of substrates and downstream effectors. Comparing wild-type and kinase-dead or knockout cells reveals receptor-dependent phosphorylation sites.

RNA-seq measures transcriptional changes downstream of receptor kinase activity, including SMAD-dependent and non-Smad target genes. It is commonly used after receptor knockout or point-mutation knock-in to define pathway outputs.

Fluorescent tagging of receptors and downstream SMADs enables live-cell imaging of receptor localization, complex assembly and nuclear translocation. Reporter assays can quantify transcriptional responses to receptor activity.

In vitro kinase assays using recombinant receptor kinase domains and substrate peptides measure catalytic activity, ATP dependence and inhibitor sensitivity. These assays help validate point mutations and drug candidates.

Researchers studying transmembrane receptor protein serine/threonine kinase activity-related genes often need to determine whether a candidate gene is causally involved in a signaling output or disease phenotype. EDITGENE provides CRISPR-based cell model and screening services that enable precise, reproducible interrogation of GO:0004675-related genes in human cells and organoids.

GO:0004675, transmembrane receptor protein serine/threonine kinase activity, is a fundamental molecular function that links extracellular signals to intracellular serine/threonine phosphorylation and diverse downstream pathways. Its dysregulation contributes to cancer, fibrosis and vascular disease, making it a high-value target for mechanistic and therapeutic research. CRISPR-based cell models and multi-omics methods provide powerful tools to dissect this activity and its disease relevance.